• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

FDA:GR

30.300 EUR 1.007 3.44%

As of 03:33:48 ET on 12/29/2014.

Snapshot for Akorn Inc (FDA)

Open: 30.295 Day's Range: 29.932 - 30.300 Volume: 0
Previous Close: 29.293 52wk Range: 14.990 - 36.500 1-Yr Rtn: +67.05%

Stock Chart for FDA

No chart data available.
  • FDA:GR 30.300
  • 1D
  • 1M
  • 1Y
29.293
Interactive FDA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FDA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 31.5294
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 1.1330
Est. PEG Ratio 1.0891
Market Cap (M EUR) 3,158.69
Shares Outstanding (M) 107.83
30 Day Average Volume 174
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FDA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FDA

Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.

Rajat Rai "Raj"Chief Executive OfficerTimothy A Dick "Tom"CFO/Investor Relations
Bruce KutinskyChief Operating OfficerMark M SilverbergExec VP: Quality Assurance
More Company Profile & Key Executives for FDA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil